This means there is an opportunity to develop alternate, potentially more effective, treatments for ovarian cancer within the current landscape. Ovarian cancer treatment hinges on disease stage ...

An MRI-based imaging technique predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models. An MRI-based imaging ...

And may spread to other areas of the body. Ovarian cancer can affect women, some transgender men and non-binary people assigned female at birth. The main treatments for ovarian cancer are surgery and ...

A new type of intensive chemotherapy is proving highly effective in treating women desperately ill with ovarian cancer, scientists announced today. The pioneering treatment is successful in 80% of ...

And may spread to other areas of the body. Ovarian cancer can affect women, some transgender men and non-binary people assigned female at birth. The main treatments for ovarian cancer are surgery and ...

(RTTNews) - Biopharmaceutical company Verastem Oncology (VSTM) Monday said that its treatment for a rare form of ovarian cancer has been given priority review by the Food and Drug Administration.

An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in patient ...

Future Oncol. 2012;8(9):1135-1147.

Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival.

Ovarian cancer ... markers of ovarian cancer. Doctor Debernardo and his team are also part of the first international trial of its kind, using CAR t-cell therapy for treatment.

When compared to the broader market, Verastem Oncology has shown exceptional performance. The company’s stock has surged 30.57% year-to-date, a stark contrast to the S&P 500’s meager performance of -0 ...

Medicare covers screenings, diagnostic testing, FDA-approved treatment, and continued monitoring for cancer, including ovarian cancer. Medicare does not cover experimental cancer treatments.